383
Views
6
CrossRef citations to date
0
Altmetric
Review Article

Leukotriene receptor antagonists for small-airway abnormalities in asthmatics: a systematic review and meta-analysis

, , &
Pages 695-704 | Received 02 Feb 2013, Accepted 12 May 2013, Published online: 25 Jun 2013

References

  • Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2012
  • O'Byrne P M, Postma DS. The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. Am J Respir Crit Care Med 1999;159:S41–S63
  • Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, Hogg JC. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997;100:44–51
  • Minshall EM, Hogg JC, Hamid QA. Cytokine mRNA expression in asthma is not restricted to the large airways. J Allergy Clin Immunol. 1998;101:386–390
  • Taha RA, Minshall EM, Miotto D, Shimbara A, Luster A, Hogg JC, Hamid QA. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol 1999;103:476–483
  • Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur Respir J 1997;10:292–300
  • Faul JL, Tormey VJ, Leonard C, Burke CM, Farmer J, Horne SJ, Poulter LW. Lung immunopathology in cases of sudden asthma death. Eur Respir J 1997;10:301–307
  • Christodoulopoulos P, Leung DY, Elliott MW, Hogg JC, Muro S, Toda M, Laberge S, et al. Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma. J Allergy Clin Immunol 2000;106:479–484
  • Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996;154:1505–1510
  • Kraft M, Martin RJ, Wilson S, Djukanovic R, Holgate ST. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999;159:228–234
  • Ranga V, Kleinerman J. Structure and function of small airways in health and disease. Arch Pathol Lab Med 1978;102:609–617
  • Macklem PT, Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J Appl Physiol 1967;22:395–401
  • Wagner EM, Liu MC, Weinmann GG, Permutt S, Bleecker ER. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 1990;141:584–588
  • Bergeron C, Hauber HP, Gotfried M, Newman K, Dhanda R, Servi RJ, Ludwig MS, et al. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. J Allergy Clin Immunol 2005;116:983–989
  • Dolhnikoff M, da Silva LF, de Araujo BB, Gomes HA, Fernezlian S, Mulder A, Lindeman JH, et al. The outer wall of small airways is a major site of remodeling in fatal asthma. J Allergy Clin Immunol 2009;123:1090–1097
  • Contoli M, Bousquet J, Fabbri LM, Magnussen H, Rabe KF, Siafakas NM, Hamid Q, et al. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy 2010;65:141–151
  • Contoli M, Kraft M, Hamid Q, Bousquet J, Rabe KF, Fabbri LM, Papi A. Do small airway abnormalities characterize asthma phenotypes? In search of proof. Clin Exp Allergy 2012;42:1150–1160
  • Scichilone N, Battaglia S, Olivieri D, Bellia V. The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1? Allergy 2009;64:1563–1569
  • King GG, Salome CM. Multimodality measurements of small airways disease. Eur Respir J 2006;27:250–252
  • Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948–968
  • Nieto A, Pamies R, Oliver F, Medina A, Caballero L, Mazon A. Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study). Respir Med 2006;100:1180–1185
  • Ohbayashi H, Shibata N, Hirose T, Adachi M. Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study. Pulm Pharmacol Ther 2009;22:574–579
  • van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006;27:951–956
  • Verbanck S, Thompson BR, Schuermans D, Kalsi H, Biddiscombe M, Stuart-Andrews C, Hanon S, et al. Ventilation heterogeneity in the acinar and conductive zones of the normal ageing lung. Thorax 2012;67:789–795
  • Gershman NH, Liu H, Wong HH, Liu JT, Fahy JV. Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. J Allergy Clin Immunol 1999;104:322–328
  • Rottier BL, Cohen J, van der Mark TW, Douma WR, Duiverman EJ, ten Hacken NH. A different analysis applied to a mathematical model on output of exhaled nitric oxide. J Appl Physiol (Bethesda, MD: 1985). 2005;99:378–379
  • Busacker A, Newell JD, Jr. Keefe T, Hoffman EA, Granroth JC, Castro M, Fain S, et al. A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest 2009;135:48–56
  • Kasahara K, Shiba K, Ozawa T, Okuda K, Adachi M. Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax 2002;57:242–246
  • Gentile DA, Skoner DP. New asthma drugs: small molecule inhaled corticosteroids. Curr Opin Pharmacol 2010;10:260–265
  • Hamid Q. Pathogenesis of small airways in asthma. Respiration 2012;84:4–11
  • Hay DW. Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction. Chest 1997;111:35S–45S
  • Hoshino M, Nakamura Y, Sim JJ. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax 1998;53:21–27
  • Crooke ST, Sarau H, Saussy D, Winkler J, Foley J. Signal transduction processes for the LTD4 receptor. Adv Prostaglandin Thromboxane Leukot Res 1990;20:127–137
  • Henderson WR, Jr. Lewis DB, Albert RK, Zhang Y, Lamm WJ, Chiang GK, Jones F, et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J exp med 1996;184:1483–1494
  • Henderson WR, Jr. Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M, et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002;165:108–116
  • Henderson WR, Jr. Chiang GK, Tien YT, Chi EY. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med 2006;173:718–728
  • Currie GP, Lipworth BJ. Bronchoprotective effects of leukotriene receptor antagonists in asthma: a meta-analysis. Chest 2002;122:146–150
  • Storms W, Michele TM, Knorr B, Noonan G, Shapiro G, Zhang J, Shingo S, et al. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years. Clin Exp Allergy 2001;31:77–87
  • Ducharme F, Schwartz Z, Hicks G, Kakuma R. Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 2004;2:CD003133
  • Cao Y, Wang J, Bunjhoo H, Xie M, Xu Y, Fang H. Comparison of leukotriene receptor antagonists in addition to inhaled corticosteroid and inhaled corticosteroid alone in the treatment of adolescents and adults with bronchial asthma: a meta-analysis. Asian Pac J Allergy Immunol 2012;30:130–138
  • Zeidler MR, Kleerup EC, Goldin JG, Kim HJ, Truong DA, Simmons MD, Sayre JW, et al. Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J 2006;27:307–315
  • Higgins JPT GS. (2011). Cochrane hand book for systematic reviews of interventions version 5.1.0. updated 2011
  • Brozek JOA, Schünemann H. GRADEpro. 3.6 for Windows. 2008
  • Havlucu Y, Yilmaz G, Goktan C, Yorgancioglu A. Usefulness of HRCT determining the distal airway inflammation in asthma. ERS 2005: Advances in pulmonary radiology; 2005 Sep 19; Copenhagen; 2005. p. 2072
  • Larsen GL, Morgan W, Heldt GP, Mauger DT, Boehmer SJ, Chinchilli VM, Lemanske RF, Jr. et al. Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma. J Allergy Clin Immunol 2009;123:861–867; e1
  • Spahn JD, Covar RA, Jain N, Gleason M, Shimamoto R, Szefler SJ, Gelfand EW. Effect of montelukast on peripheral airflow obstruction in children with asthma. Ann Allergy Asthma Immunol 2006;96:541–549
  • Stelmach I, Grzelewski T, Bobrowska-Korzeniowska M, Stelmach P, Kuna P. A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with asthma. Pulm Pharmacol Ther 2007;20:691–700
  • Kraft M, Cairns CB, Ellison MC, Pak J, Irvin C, Wenzel S. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest 2006;130:1726–1732
  • Yasui H, Fujisawa T, Inui N, Kato M, Hashimoto D, Enomoto N, Nakamura Y, et al. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation. Respir Med 2012;106:508–514
  • McFadden ER, Jr. Linden DA. A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med 1972;52:725–737
  • Gelb AF, Zamel N. Simplified diagnosis of small-airway obstruction. N Engl J Med 1973;288:395–398
  • Frank R, Liu MC, Spannhake EW, Mlynarek S, Macri K, Weinmann GG. Repetitive ozone exposure of young adults: evidence of persistent small airway dysfunction. Am J Respir Crit Care Med 2001;164:1253–1260
  • Simon MR, Chinchilli VM, Phillips BR, Sorkness CA, Lemanske RF, Jr Szefler SJ, Taussig L, et al. Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol 2010;126:527–534; e1–e8
  • Drewek R, Garber E, Stanclik S, Simpson P, Nugent M, Gershan W. The FEF25-75 and its decline as a predictor of methacholine responsiveness in children. J Asthma 2009;46:375–381
  • Burgel PR. The role of small airways in obstructive airway diseases. Eur Respir Rev 2011;20:23–33
  • McFadden ER, Jr. Resurrection men and the FEF25-75. J Allergy Clin Immunol 2010;126:535–536
  • Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998;12:1346–1353
  • Komarow HD, Skinner J, Young M, Gaskins D, Nelson C, Gergen PJ, Metcalfe DD. A study of the use of impulse oscillometry in the evaluation of children with asthma: analysis of lung parameters, order effect, and utility compared with spirometry. Pediatr Pulmonol 2012;47:18–26
  • Goldman MD, Carter R, Klein R, Fritz G, Carter B, Pachucki P. Within- and between-day variability of respiratory impedance, using impulse oscillometry in adolescent asthmatics. Pediatr Pulmonol 2002;34:312–319
  • Meraz EG, Nazeran H, Ramos CD, Nava P, Diong B, Goldman MD, Goldman CA. Analysis of impulse oscillometric measures of lung function and respiratory system model parameters in small airway-impaired and healthy children over a 2-year period. Biomed Eng Online 2011;10:21
  • Fritscher LG, Rodrigues MT, Zamel N, Chapman KR. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med 2009;103:296–300

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.